R&D Staying on course: How hybrid FSP/FSO models are shaping cli... Biotech and pharma companies increasingly require additional agility, flexibility, and operational efficiency in their clinical research operations.
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.